Parece que ha habido un error al intentar cargar esta página.
Nuestro equipo ha sido notificado, pero contacte con nosotros usando el widget de soporte por email si el problema persiste.
Trend | Peers | Company |
---|---|---|
Is return on equity increasing? | Yes | No |
Is net profit margin increasing? | Yes | No |
Is asset turnover increasing? | Yes | Yes |
Is equity multiplier increasing? | Yes | Yes |
Competitors Used |
---|
Grupo Mateus S.A. |
Raia Drogasil S.A. |
Empreendimentos Pague Menos S.A. |
d1000 Varejo Farma Participações S.A. |
Dimed S.A. Distribuidora de Medicamentos |
Return on Equity Benchmarks | ||||||||
Comparable Companies | ||||||||
GMAT3 | RADL3 | PGMN3 | DMVF3 | PNVL3 | ASAI3 | |||
Return On Equity | ||||||||
Latest Twelve Months | 15% | 19% | 2% | 2% | 8% | 16% | ||
Fiscal Year - 1 | 15% | 19% | 0% | 2% | 8% | 17% | ||
Fiscal Year - 2 | 15% | 20% | 12% | 1% | 8% | 37% | ||
Fiscal Year - 3 | 13% | 17% | 8% | 0% | 8% | 78% | ||
Fiscal Year - 4 | 19% | 12% | 6% | 0% | 7% | 33% | ||
Fiscal Year - 5 | 20% | 21% | -1% | -2% | 16% | 19% | ||
Average | 16% | 18% | 5% | 1% | 9% | 33% | ||
Median | 15% | 19% | 4% | 1% | 8% | 26% | ||
Benchmarks | Ticker | |||||||
Grupo Mateus S.A. | BOVESPA:GMAT3 | |||||||
Raia Drogasil S.A. | BOVESPA:RADL3 | |||||||
Empreendimentos Pague Menos S.A. | BOVESPA:PGMN3 | |||||||
d1000 Varejo Farma Participações S.A. | BOVESPA:DMVF3 | |||||||
Dimed S.A. Distribuidora de Medicamentos | BOVESPA:PNVL3 |
Financial Performance | ||||||||
Comparable Companies | ||||||||
(in millions) | GMAT3 | RADL3 | PGMN3 | DMVF3 | PNVL3 | ASAI3 | ||
Latest Fiscal Year | Dec-24 | Dec-24 | Dec-24 | Dec-24 | Dec-24 | Dec-24 | ||
LTM Period | Mar-25 | Jun-25 | Jun-25 | Jun-25 | Mar-25 | Mar-25 | ||
Revenues | ||||||||
Latest Twelve Months | 33,034 | 40,966 | 13,685 | 2,411 | 4,975 | 75,149 | ||
Fiscal Year | 32,085 | 38,864 | 12,642 | 2,161 | 4,942 | 73,819 | ||
Fiscal Year - 1 | 26,774 | 33,974 | 11,202 | 1,749 | 4,461 | 66,503 | ||
Fiscal Year - 2 | 21,768 | 29,067 | 9,189 | 1,483 | 3,990 | 54,520 | ||
Fiscal Year - 3 | 15,877 | 24,127 | 7,529 | 1,141 | 3,225 | 41,898 | ||
Fiscal Year - 4 | 12,397 | 20,067 | 6,858 | 1,004 | 2,819 | 36,043 | ||
Fiscal Year - 5 | 8,036 | 17,566 | 6,422 | 1,132 | 2,725 | 28,082 | ||
Net Income | ||||||||
Latest Twelve Months | 1,395 | 1,223 | 60 | 19 | 97 | 826 | ||
Fiscal Year | 1,318 | 1,198 | 0 | 26 | 106 | 769 | ||
Fiscal Year - 1 | 1,221 | 1,055 | 0 | 21 | 93 | 710 | ||
Fiscal Year - 2 | 1,052 | 996 | 264 | 11 | 86 | 1,220 | ||
Fiscal Year - 3 | 759 | 752 | 164 | 2 | 79 | 1,610 | ||
Fiscal Year - 4 | 726 | 484 | 96 | 0 | 56 | 1,398 | ||
Fiscal Year - 5 | 338 | 772 | (7) | (7) | 77 | 1,063 | ||
Total Assets | ||||||||
Latest Fiscal Quarter Prior | 16,519 | 20,706 | 8,584 | 1,652 | 3,204 | 41,711 | ||
Latest Fiscal Quarter | 20,116 | 23,052 | 9,116 | 1,893 | 3,175 | 44,685 | ||
Fiscal Year | 18,959 | 22,142 | 8,984 | 1,834 | 3,377 | 45,593 | ||
Fiscal Year - 1 | 16,357 | 20,094 | 8,989 | 1,549 | 3,077 | 43,177 | ||
Fiscal Year - 2 | 13,264 | 17,185 | 8,597 | 1,471 | 2,733 | 40,618 | ||
Fiscal Year - 3 | 9,955 | 14,776 | 6,573 | 1,471 | 2,381 | 22,854 | ||
Fiscal Year - 4 | 8,199 | 13,828 | 5,754 | 1,455 | 2,194 | 18,821 | ||
Fiscal Year - 5 | 4,121 | 12,248 | 4,808 | 1,096 | 1,460 | 35,905 | ||
Fiscal Year - 6 | 3,391 | 7,352 | 3,377 | 1,015 | 1,000 | 9,954 | ||
Common Equity | ||||||||
Latest Fiscal Quarter Prior | 8,814 | 6,177 | 2,638 | 883 | 1,197 | 4,698 | ||
Latest Fiscal Quarter | 10,014 | 6,672 | 2,778 | 902 | 1,246 | 5,385 | ||
Fiscal Year | 9,850 | 6,429 | 2,715 | 897 | 1,235 | 5,255 | ||
Fiscal Year - 1 | 8,672 | 5,956 | 2,653 | 871 | 1,173 | 4,630 | ||
Fiscal Year - 2 | 7,456 | 5,341 | 2,335 | 849 | 1,108 | 3,896 | ||
Fiscal Year - 3 | 6,403 | 4,678 | 2,090 | 838 | 1,046 | 2,766 | ||
Fiscal Year - 4 | 5,644 | 4,363 | 1,941 | 836 | 1,011 | 1,347 | ||
Fiscal Year - 5 | 1,889 | 4,025 | 1,025 | 466 | 524 | 7,098 | ||
Fiscal Year - 6 | 1,541 | 3,500 | 1,031 | 492 | 464 | 4,209 |